Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.

One problem is that researchers are often in competition ... Adam is an experienced medical writer and statistician. Before setting up Dianthus Medical in 1999, he worked as a medical writer ...

Have the giants gotten too big for anyone’s good? This week, the top 10 companies in the S&P 500 made up more than 37.5% of the index’s total market value. Many market commentators will tell ...

The cycle is: the news media and public ignore a serious problem for years; for some reason, they suddenly notice, declare it a crisis and concoct a solution; next they realize the problem will not be ...

“Turbulence was and still is an unsolved problem in the sense that we cannot exactly simulate realistic flows on computers, i.e. we still need a wind tunnel to design an aircraft wing. But ...